Funding Breakdown
|
| Development Components |
Cost (US) |
Description |
| Pre-clinical Studies |
$70,000 |
We will perform preclinical trials on pig models. The studies will include looking for hemorrhagic and ischemic stroke biomarkers on pigs with induced stroke and pigs with no stroke. Other preclinical studies will include test for portability by testing RHISE’s functionality on a moving vehicle and others. |
| Prototype Development |
$30,000 |
As the research and development of the solution advances, our prototype will need to deliver the safety and performance criteria |
| Fabrication Expansion |
$140,000 |
The mass production of RHISE will be initially scaled up for the creation of 20000 units approximately. The fabrication expansion will focus on lean production and continuous improved manufacturing. |
| FDA Application |
$3,382 |
Registration and application for FDA approval for premarket studies and commercialization. |
| Clinical Trials |
$1,000,000 |
Our clinical trials will required 250 to 500 participants. We will collect peripheral blood samples from patients with stroke symptoms without affecting current diagnostic processes of the patients. Then RHISE’s results will be compared with computer tomography results to determine its accuracy and reliability. |
